Results 131 to 140 of about 1,385 (169)

Structural and functional evolution of IL-1 targeting: From systemic neutralization to bioengineered nanotherapies. [PDF]

Mater Today Bio
Yang L, Chen G, Lyu Z.
europepmc   +1 more source

A shark-derived broadly neutralizing nanobody targeting a highly conserved epitope on the S2 domain of sarbecoviruses. [PDF]

J Nanobiotechnology
Feng B, Li C, Zhang Z, Huang Y, Liu B, Zhang Z, Luo J, Wang Q, Yin L, Chen S, He P, Xiong X, Zhao J, Niu X, Chen Z, Chen L.   +15 more
europepmc   +1 more source

Daily Herald, December, 09, 1971 [PDF]

, 1971

core  

Marine Natural Products as Anticancer Agents 3.0. [PDF]

Mar Drugs
Alves C, Diederich M.
europepmc   +1 more source

Nanobody fusion enhances production of difficult-to-produce secretory proteins. [PDF]

J Biol Chem
Yan R, Zhang Y, Zhang H, Ma J.
europepmc   +1 more source

CAR-Toner: an AI-driven approach for CAR tonic signaling prediction and optimization. [PDF]

Cell Res
Qiu S, Chen J, Wu T, Li L, Wang G, Wu H, Song X, Liu X, Wang H.   +8 more
europepmc   +1 more source

PROSCA: an online platform for humanized scaffold mining facilitating rational protein engineering. [PDF]

Nucleic Acids Res
Wang X, Zhang Y, Li Z, Duan Z, Guo M, Wang Z, Zhu F, Xue W.   +7 more
europepmc   +1 more source

Identification and transcriptional characterisation of novel inhibitors of NAV1.7 AND TRKB [PDF]

, 2018
Hompoonsup, Supanida
core  

Editorial: Peptidases as a therapeutic target in anti-cancer management. [PDF]

Front Pharmacol
Mitrović A, Burden RE, Softič A, Kavčič N.   +3 more
europepmc   +1 more source

CHOサイボウヲモチイタナンハツゲンサメIgNARコウタイセイサン：ボトルネックノカイメイトセイサンセイカイゼンノココロミ [PDF]

Lyu, Xiaofang, リュー, シャウファン, 呂, 小芳   +2 more
core   +1 more source